Kolon TissueGene, Inc.

950160· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩20,750-4.16%

2026-08-21

Financials

Valuation Metrics

Kolon TissueGene, Inc.'s Market Cap is ₩1.8T. At end of 2025 it was ₩6.8T. Ranked #224 of 2,427 in KR market (top 9%), #49 of 1,645 on KOSDAQ (top 3%), #23 of 233 in Pharmaceuticals, Biotechnology & Life Sciences (top 10%) by Market Cap.

Investment Metrics(as of 2026-08-22)

Metric	Value	Rank
Size
Market Cap	1.76T KRW	KR#224/2,427 Sec#23/233
Revenue	4.94B KRW	KR—/2,427 Sec—/233
Net Income	-185.78B KRW	KR—/2,427 Sec—/233
Total Assets	513.26B KRW	KR—/2,427 Sec—/233
Net Assets	204.15B KRW	KR—/2,427 Sec—/233
Value
P/B	8.64x	KR#2,351/2,427 Sec#208/233
P/S	356.89x	KR#2,410/2,427 Sec#222/233
FCF Yield	-1.45%	KR—/2,427 Sec—/233
Profitability
ROE	-91.00%	KR—/2,427 Sec—/233
ROA	-36.20%	KR—/2,427 Sec—/233
Op. Margin	-501.38%	KR—/2,427 Sec—/233
Revenue Growth	-15.21%	KR—/2,427 Sec—/233
Financial Health
Debt Ratio	151.42%	KR—/2,427 Sec—/233
Total Debt	57.52B KRW	KR—/2,427 Sec—/233
FCF	-25.49B KRW	KR—/2,427 Sec—/233
Cash	67.58B KRW	KR—/2,427 Sec—/233
Performance
1Y Return	-42.84%	KR#1,930/2,427 Sec#181/233
1M Return	-30.95%	KR#2,350/2,427 Sec#228/233
From 52W High	-86.07%	KR#2,397/2,427 Sec#231/233
1Y MDD	-91.59%	KR#2,412/2,427 Sec#232/233
Trading
Volume	2,099,137 shares	KR#55/2,427 Sec#4/233
Trading Value	43.46B KRW	KR#85/2,427 Sec#6/233
Foreign Own.	5.17%	KR—/2,427 Sec—/233
Per Share
EPS	-2,186 KRW	KR—/2,427 Sec—/233
BPS	2,403 KRW	KR#1,956/2,427 Sec#158/233